DIPLOMAT PHARMACY INC (DPLO) Stock Price & Overview

NYSE:DPLO

Current stock price

4
+0.01 (+0.25%)
At close:
4
0 (0%)
After Hours:

The current stock price of DPLO is 4 null. Today DPLO is up by 0.25%. In the past month the price increased by 0.25%. In the past year, price decreased by -69.47%.

DPLO Key Statistics

52-Week Range2.43 - 14.46
Current DPLO stock price positioned within its 52-week range.
1-Month Range3.98 - 4.12
Current DPLO stock price positioned within its 1-month range.
Market Cap
304.004M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.54
Dividend Yield
N/A

DPLO Stock Performance

Today
+0.25%
1 Week
+0.50%
1 Month
+0.25%
3 Months
-35.38%
Longer-term
6 Months -30.07%
1 Year -69.47%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

DPLO Stock Chart

DIPLOMAT PHARMACY INC / DPLO Daily stock chart

DPLO Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to DPLO. When comparing the yearly performance of all stocks, DPLO is a bad performer in the overall market: 97.95% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

DPLO Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to DPLO. Both the profitability and financial health of DPLO have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

DPLO Earnings

Next Earnings DateN/A
Last Earnings DateN/A

DPLO Forecast & Estimates


Analysts
Analysts56
Price TargetN/A
EPS Next Y-560%
Revenue Next YearN/A

DPLO Financial Highlights

Over the last trailing twelve months DPLO reported a non-GAAP Earnings per Share(EPS) of -0.5399999999999999. The EPS decreased by -198.18% compared to the year before.


Income Statements
Revenue(TTM)5.21B
Net Income(TTM)-649.07M
Industry RankSector Rank
PM (TTM) -12.47%
ROA -55.83%
ROE N/A
Debt/Equity 0.18
Chartmill High Growth Momentum
EPS Q2Q%-102178.26%
Sales Q2Q%-5.25%
EPS 1Y (TTM)-198.18%
Revenue 1Y (TTM)-1.53%

DPLO Ownership

Ownership
Inst Owners83.92%
Shares76.00M
Float19.51M
Ins Owners1.72%
Short Float %N/A
Short RatioN/A

About DPLO

Company Profile

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. It aids in the dispensing, delivery, dosing and reimbursement of clinically intensive and specialty drugs. The company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Diplomat Pharmacy, Inc. is headquartered in Flint, Michigan.

Company Info

DIPLOMAT PHARMACY INC

4100 S. SAGINAW ST.

FLINT MI 48507

CEO: Brian T. Griffin

Phone: 888-720-4450

DIPLOMAT PHARMACY INC / DPLO FAQ

What does DPLO do?

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. It aids in the dispensing, delivery, dosing and reimbursement of clinically intensive and specialty drugs. The company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Diplomat Pharmacy, Inc. is headquartered in Flint, Michigan.


What is the current price of DPLO stock?

The current stock price of DPLO is 4 null. The price increased by 0.25% in the last trading session.


What is the dividend status of DIPLOMAT PHARMACY INC?

DPLO does not pay a dividend.


How is the ChartMill rating for DIPLOMAT PHARMACY INC?

DPLO has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Is DIPLOMAT PHARMACY INC (DPLO) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on DPLO.


Who owns DIPLOMAT PHARMACY INC?

You can find the ownership structure of DIPLOMAT PHARMACY INC (DPLO) on the Ownership tab.